Found: 33
Select item for more details and to access through your institution.
Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Antiretroviral Therapy Improves Acquired Immunodeficiency Syndrome with Systemic Lupus Erythematosus.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 6, p. 463, doi. 10.3390/life11060463
- By:
- Publication type:
- Article
Novel prognostic predictor of haemoglobin–platelet index in diffuse large B‐cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL‐6 production in lymphoma cells.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. 360, doi. 10.1111/bjh.18208
- By:
- Publication type:
- Article
Tumour‐immune microenvironment in duodenal‐type follicular lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 2, p. 243, doi. 10.1111/bjh.16715
- By:
- Publication type:
- Article
Interleukin‐17‐producing angioimmunoblastic T‐cell lymphoma with Evans syndrome.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Antidiuretic hormone‐ and interleukin‐6‐producing angioimmunoblastic T‐cell lymphoma associated with syndrome of inappropriate antidiuretic hormone secretion.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Clathrin Assembly Protein CALM Plays a Critical Role in KIT Signaling by Regulating Its Cellular Transport from Early to Late Endosomes in Hematopoietic Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109441
- By:
- Publication type:
- Article
The Clathrin Assembly Protein PICALM Is Required for Erythroid Maturation and Transferrin Internalization in Mice.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031854
- By:
- Publication type:
- Article
Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 5, p. 979, doi. 10.1007/s00277-022-04801-2
- By:
- Publication type:
- Article
Multiple cytokine-producing aggressive EBV-positive diffuse large B cell lymphoma, not otherwise specified with hemophagocytic syndrome.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab.
- Published in:
- Cancers, 2018, v. 10, n. 9, p. 304, doi. 10.3390/cancers10090304
- By:
- Publication type:
- Article
MCL-041: Outcomes for Recurrent Mantle Cell Lymphoma Post-BTK Inhibitor Therapy in Japan: An Administrative Database Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S407, doi. 10.1016/S2152-2650(21)01918-2
- By:
- Publication type:
- Article
Poster: MCL-041: Outcomes for Recurrent Mantle Cell Lymphoma Post-BTK Inhibitor Therapy in Japan: An Administrative Database Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S247, doi. 10.1016/S2152-2650(21)01554-8
- By:
- Publication type:
- Article
Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 4, p. 416, doi. 10.3390/v12040416
- By:
- Publication type:
- Article
Polatuzumab Vedotin plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Results from the Phase III POLARIX Study
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 56
- By:
- Publication type:
- Article
Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2023, v. 63, n. 2, p. 99, doi. 10.3960/jslrt.23001
- By:
- Publication type:
- Article
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 5, p. 621, doi. 10.1007/s12185-024-03834-9
- By:
- Publication type:
- Article
End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 6, p. 677, doi. 10.1007/s12185-024-03738-8
- By:
- Publication type:
- Article
CD34<sup>+</sup> myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence.
- Published in:
- 2022
- By:
- Publication type:
- journal article
C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial.
- Published in:
- International Journal of Hematology, 2021, v. 114, n. 2, p. 205, doi. 10.1007/s12185-021-03148-0
- By:
- Publication type:
- Article
Excessive Reactive Iron Impairs Hematopoiesis by Affecting Both Immature Hematopoietic Cells and Stromal Cells.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 3, p. 226, doi. 10.3390/cells8030226
- By:
- Publication type:
- Article
Mice doubly-deficient in the Arf GAPs SMAP1 and SMAP2 exhibit embryonic lethality.
- Published in:
- FEBS Letters, 2015, v. 589, n. 19PartB, p. 2754, doi. 10.1016/j.febslet.2015.07.050
- By:
- Publication type:
- Article
Outcomes for Recurrent Mantle Cell Lymphoma Post-Ibrutinib Therapy: A Retrospective Cohort Study from a Japanese Administrative Database.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Interim PET‐guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced‐stage classic Hodgkin lymphoma (JCOG1305).
- Published in:
- Cancer Science, 2024, v. 115, n. 10, p. 3384, doi. 10.1111/cas.16281
- By:
- Publication type:
- Article
Two‐year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemia.
- Published in:
- Cancer Science, 2022, v. 113, n. 6, p. 2085, doi. 10.1111/cas.15344
- By:
- Publication type:
- Article
Decreased expression of T‐cell‐associated immune markers predicts poor prognosis in patients with follicular lymphoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 2, p. 660, doi. 10.1111/cas.15224
- By:
- Publication type:
- Article
Phase II study of tazemetostat for relapsed or refractory B‐cell non‐Hodgkin lymphoma with EZH2 mutation in Japan.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3627, doi. 10.1111/cas.15040
- By:
- Publication type:
- Article
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma.
- Published in:
- Cancer Science, 2021, v. 112, n. 7, p. 2845, doi. 10.1111/cas.14937
- By:
- Publication type:
- Article
A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström's macroglobulinemia.
- Published in:
- Cancer Science, 2020, v. 111, n. 9, p. 3327, doi. 10.1111/cas.14561
- By:
- Publication type:
- Article
Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-17666-8
- By:
- Publication type:
- Article
Genital Infection as a First Sign of Acute Myeloid Leukemia.
- Published in:
- Case Reports in Dermatology, 2010, v. 2, n. 1, p. 18, doi. 10.1159/000279328
- By:
- Publication type:
- Article